Turku University Hospital
Turku, 20521, Finland
NCT Number: NCT01843582
The study is aimed to develop a new reaction-time based method for examining the visual field and to study the effect of refractive error on the magnification of a fundus photograph in order to evaluate the true size of a retinal feature.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Turku, 20521, Finland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: one measurement at the start of the study
Measurement is done on a fundus photograph (one visit and one examination for each patient)
Time frame: one measurement at the start of the study
The location of the blind spot is screened using Octopus custom made visual field program at the one visit (one visit and one study for each patient) and a novel reaction-time based visual field device.
Turku University Hospital
Other Gov
A Study to Develop Both a Novel Method for Evaluating the True Size of a Retinal Object on Fundus Photographs and a New Reaction-time Based Method for Studying the Visual Field on Healthy Volunteers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06986954
Aneurysm, False, Bleed Intracranial
Darien, Connecticut, United States
View Trial DetailsNCT05053932
Anemia, Anemia, Hemolytic
Paris, IDF, France
View Trial DetailsNCT06154265
Arterial Occlusive Diseases, Arteriosclerosis
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT05515874
Arterial Occlusive Diseases, Arteriosclerosis
Chicago, Illinois, United States
View Trial Details